Brigatinib/Brigatinib detailed instructions
1. Indications and Usage
Brigatinib is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer in a U.S. Food and Drug Administration (FDA)-approved test.

2. Dosage and usage
For the first 7 days, take 90 mg orally once a day mg , then increase to 180 mg orally once a day 180 mg. It can be eaten with or without food.
Three. Dosage form and strength
Tablets: 180mg, 90mg or 30mg.
Four. Contraindications
No.
Five. Warnings and Precautions
1.Interstitial lung disease (ILD)/Pneumonia:Monitor for new or worsening respiratory symptoms, particularly during the first week of treatment. If new or worsening respiratory symptoms occur, discontinue brigatinib and promptly evaluate for ILD/pneumonitis. After recovery, either reduce the dose or permanently discontinue brigatinib.
2.Hypertension: Monitor blood pressure after 2 weeks and at least once a month during treatment. For severe hypertension, discontinue brigatinib and then reduce the dose or permanently discontinue the drug.
3.Bradycardia:Monitor heart rate and blood pressure regularly during treatment. If symptoms occur, discontinue brigatinib and then reduce dose or permanently discontinue brigatinib.
4.Visual Impairment:Patients are advised to report visual symptoms. Discontinue brigatinib and obtain ophthalmologic evaluation, then reduce dose or permanently discontinue brigatinib.
5.Elevated creatine phosphokinase:Monitor CPK levels regularly during treatment. Discontinue brigatinib and resume or reduce dose based on severity and muscle pain or weakness.
6.Elevated pancreatic enzymes:Monitor lipase and amylase levels regularly during treatment. Depending on severity, withhold brigatinib and then resume or reduce dose.
7.Hepatotoxicity:Monitor alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin levels regularly during treatment. Depending on severity, withhold dosage and then resume at lower levels.
8.Hyperglycemia:Assess fasting blood glucose before starting brigatinib and periodically during treatment. If adequate control is not achieved with optimal medical management, brigatinib should be withheld and dose reduction or permanent discontinuation should be considered based on severity.
9.Photosensitivity:Patients are advised to limit sun exposure. Based on severity, discontinue brigatinib and resume at the same dose, reduce the dose, or permanently discontinue.
10.Embryo-Fetal Toxicity:can cause fetal harm, inform women of potential risks to the fetus with reproductive potential, and use effective contraceptive measures.
6. Adverse reactions
Brigatinib/BrigatinibThe most common adverse reactions (≥25%) are diarrhea, fatigue, nausea, rash, cough, myalgia, headache, hypertension, vomiting and dyspnea.
7. Drug interactions
CYP3AInhibitors:Avoid taking brigatinib concomitantly with strong or moderateCYP3A inhibitors. If concomitant use of strong or moderateCYP3A cannot be avoidedInhibitors, the dose of brigatinib should be reduced.
CYP3AInducers:Avoid coadministration of brigatinib with strong or moderate CYP3A inducers. If coadministration of moderate CYP3Ainducers is unavoidable, increase the dose of brigatinib.
8. Use among specific groups of people
Liver Impairment: Reduce the brigatinib dose in patients with severe hepatic impairment.
Renal Impairment: Reduce the brigatinib dose in patients with severe renal impairment.
Breastfeeding:Breastfeeding is not recommended.
Generic drugs of this drug are produced in Laos and Bangladesh, and they are all officially marketed generic drugs. The retail price of Laos United Pharmaceuticals90mg30pills900 is about 1,000 yuan. The retail price of Laos and ASEAN pharmaceuticals is 90mg21pills1900 The retail price of Beacon Pharmaceutical in Bangladesh is about 90mg30pills3200yuan, and the retail price of Yaopin International Pharmaceutical in Bangladesh is about 90mg30pills2200yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.
xa0
xa0
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)